[go: up one dir, main page]

WO2000079267A3 - Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer - Google Patents

Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer Download PDF

Info

Publication number
WO2000079267A3
WO2000079267A3 PCT/GB2000/002446 GB0002446W WO0079267A3 WO 2000079267 A3 WO2000079267 A3 WO 2000079267A3 GB 0002446 W GB0002446 W GB 0002446W WO 0079267 A3 WO0079267 A3 WO 0079267A3
Authority
WO
WIPO (PCT)
Prior art keywords
usp25
specific protease
ubiquitin
hte
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2000/002446
Other languages
French (fr)
Other versions
WO2000079267A2 (en
Inventor
Dean Nizetic
Juergen Groet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914589.8A external-priority patent/GB9914589D0/en
Priority claimed from GB0008161A external-priority patent/GB0008161D0/en
Application filed by University College London filed Critical University College London
Priority to AU55524/00A priority Critical patent/AU5552400A/en
Publication of WO2000079267A2 publication Critical patent/WO2000079267A2/en
Publication of WO2000079267A3 publication Critical patent/WO2000079267A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The product of a gene located at human chromosome 21q11-21 has ubiquitin specific protease activity and binds to ubiquitin, polyubiquitin, ubiquitin-like protein SUMO-3, and proteins which are implicated in the repair/excision of DNA. It is believed to have a role in regulating cell growth, cell growth arrest and/or apoptosis and is implicated in carcinoma growth. The gene has been sequenced and cloned into a microorganism and the product's effect on cell growth is to be investigated. The gene has GenBank accession number AF134213 and has the HUGO-approved name USP25.
PCT/GB2000/002446 1999-06-22 2000-06-22 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer Ceased WO2000079267A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU55524/00A AU5552400A (en) 1999-06-22 2000-06-22 Treatment of cancer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9914589.8A GB9914589D0 (en) 1999-06-22 1999-06-22 Diagnosis and treatment of alzheimers diease
GB9914589.8 1999-06-22
GB0008161A GB0008161D0 (en) 2000-04-03 2000-04-03 Treatment of cancer
GB0008161.2 2000-04-03

Publications (2)

Publication Number Publication Date
WO2000079267A2 WO2000079267A2 (en) 2000-12-28
WO2000079267A3 true WO2000079267A3 (en) 2001-02-15

Family

ID=26244028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/002446 Ceased WO2000079267A2 (en) 1999-06-22 2000-06-22 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer

Country Status (2)

Country Link
AU (1) AU5552400A (en)
WO (1) WO2000079267A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709839B1 (en) * 1999-09-24 2004-03-23 Rigel Pharmaceuticals, Inc. SYK-UBP proteins, compositions and methods of use
EP1240335A2 (en) * 1999-12-23 2002-09-18 Incyte Genomics, Inc. Proteases
US6846663B2 (en) 2001-01-12 2005-01-25 California Institute Of Technology Regulation of target protein activity through modifier proteins
US7122332B2 (en) * 2001-03-29 2006-10-17 Rigel Pharmaceuticals, Inc. Modulators of leukocyte activation, compositions and methods of use
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
EP1771194A2 (en) * 2004-07-07 2007-04-11 Biodevelops Pharma Entwicklung GmbH Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046289A1 (en) * 1998-03-12 1999-09-16 Human Genome Sciences, Inc. 31 human secreted proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046289A1 (en) * 1998-03-12 1999-09-16 Human Genome Sciences, Inc. 31 human secreted proteins

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CAVANI SIMONA ET AL: "Cytogenetic and molecular study of 32 Down syndrome families: Potential leukaemia predisposing role of the most proximal segment of chromosome 21q.", BRITISH JOURNAL OF HAEMATOLOGY, vol. 103, no. 1, October 1998 (1998-10-01), pages 213 - 216, XP000943387, ISSN: 0007-1048 *
DATABASE EMBL 24 June 1997 (1997-06-24), STRAUSBERG, R.: "Homo sapiens cDNA clone IMAGE:824710 5' similar to SW:UBP2-YEAST Q01476 UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2", XP002152574 *
DATABASE EMBL 29 November 1996 (1996-11-29), HILLIER, L. ET AL.: "Homo sapiens cDNA clone IMAGE:549350 5' similar to WP:K02C4.3 CE01599 UBIQUITIN CARBOXYL-TERMINAL HYDROLASE", XP002152573 *
FUJIWARA TSUTOMU ET AL: "Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease.", GENOMICS, vol. 54, no. 1, 15 November 1998 (1998-11-15), pages 155 - 158, XP002153254, ISSN: 0888-7543 *
GROET JUERGEN ET AL: "Bacteria contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome.", GENOME RESEARCH, vol. 8, no. 4, April 1998 (1998-04-01), pages 385 - 398, XP002152570, ISSN: 1088-9051 *
GROET JURGEN ET AL: "Narrowing of the region of allelic loss in 21q11-21 in squamous non-small cell lung carcinoma and cloning of a novel ubiquitin-specific protease gene from the deleted segment.", GENES CHROMOSOMES & CANCER, vol. 27, no. 2, February 2000 (2000-02-01), pages 153 - 161, XP000943091, ISSN: 1045-2257 *
HILLIER, L. ET AL.: "Generation and analysis of 280,000 human expressed sequence tags", GENOME RES., vol. 6, no. 9, 1996, pages 807 - 828, XP002922485 *
KOHNO TAKASHI ET AL: "Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma.", GENES CHROMOSOMES & CANCER, vol. 21, no. 3, March 1998 (1998-03-01), pages 236 - 243, XP000943071, ISSN: 1045-2257 *
VALERO REBECA ET AL: "USP25, a novel gene encoding a deubiquitinating enzyme, is located in the gene-poor region 21q11.2.", GENOMICS, vol. 62, no. 3, 15 December 1999 (1999-12-15), pages 395 - 405, XP002152572, ISSN: 0888-7543 *
WILKINSON KEITH D: "Regulation of ubiquitin-dependent processes by deubiquitinating enzymes.", FASEB JOURNAL, vol. 11, no. 14, December 1997 (1997-12-01), pages 1245 - 1256, XP000943130, ISSN: 0892-6638 *

Also Published As

Publication number Publication date
WO2000079267A2 (en) 2000-12-28
AU5552400A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
Zimmerman et al. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action.
Zhao et al. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines
Kjeldsen et al. Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
Duranton et al. Kinetic mechanism of the inhibition of cathepsin G by α1-antichymotrypsin and α1-proteinase inhibitor
AU4221399A (en) Human cd45+ and/or fibroblast + mesenchymal stem cells
PL361307A1 (en) Casein derived peptides and uses thereof in therapy
WO1997006255A3 (en) Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
WO2000079267A3 (en) Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer
Saraste et al. A gene in Paracoccus for subunit III of cytochrome oxidase
WO1999035277A3 (en) Recombinant, active caspases and uses thereof
WO2004009112A8 (en) Use of urease for inhibiting cancer cell growth
WO2001036465A3 (en) Human zven proteins
WO2000078934A3 (en) Use of the ubiquitin specific protease usp25 in the diagnosis and treatment of alzheimer's disease
WO2003029422A3 (en) Noonan syndrome gene
WO1997042347A3 (en) 5-lipoxygenase gene polymorphisms and their use in classifying patients
EP0785214A3 (en) Amylase inhibitors
Lei et al. Zinc-α2-glycoprotein has ribonuclease activity
AU634575B2 (en) Rna with endoribonuclease activity for mrna of ripening genes, the preparation thereof and the use thereof in plants
Santamarı&́a et al. Genomic structure and chromosomal localization of the human cathepsin O gene (CTSO)
WO2004076690A3 (en) Use of a mutation in the human gnas gene for predicting risks of disease, courses of diseases, and for predicting the response to treatments of disease
Menz et al. Matrix NADH dehydrogenases of plant mitochondria and sites of quinone reduction by complex I
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
WO2003066808A3 (en) Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
WO1999045116A3 (en) Human homolog of a nuclear migration gene and its use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP